Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pei Juan Lu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Plos One|December 8, 2022
Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancerJason Driver Tucker, Ravi Doddapaneni, Pei Juan Lu, et al.
International Journal of Cancer|September 19, 2002
PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen?Angela Barrett, Bente Madsen, John Copier, et al.
Plos One|August 20, 2025
Ribitol treatment rescues dystroglycanopathy mice with common L276I mutationBo Wu, Pei Juan Lu, Morgan Drains, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 3, 2013
Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functionsLei Xu, Pei Juan Lu, Chi-Hsien Wang, et al.
Plos One|December 1, 2022
Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse modelBo Wu, Morgan Drains, Sapana N Shah, et al.
Gene Expression Patterns : GEP|March 6, 2003
Characterisation and developmental expression of mouse Plu-1, a homologue of a human nuclear protein (PLU-1) which is specifically up-regulated in breast cancerBente Madsen, Bradley Spencer-Dene, Richard Poulsom, et al.
Mechanisms of Development|October 1, 2003
Characterisation and developmental expression of mouse Plu-1, a homologue of a human nuclear protein (PLU-1) which is specifically up-regulated in breast cancerBente Madsen, Bradley Spencer-Dene, Richard Poulsom, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|December 8, 2022
Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancerJason Driver Tucker, Ravi Doddapaneni, Pei Juan Lu, et al.
International Journal of Cancer|September 19, 2002
PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen?Angela Barrett, Bente Madsen, John Copier, et al.
Plos One|August 20, 2025
Ribitol treatment rescues dystroglycanopathy mice with common L276I mutationBo Wu, Pei Juan Lu, Morgan Drains, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 3, 2013
Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functionsLei Xu, Pei Juan Lu, Chi-Hsien Wang, et al.
Plos One|December 1, 2022
Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse modelBo Wu, Morgan Drains, Sapana N Shah, et al.
Gene Expression Patterns : GEP|March 6, 2003
Characterisation and developmental expression of mouse Plu-1, a homologue of a human nuclear protein (PLU-1) which is specifically up-regulated in breast cancerBente Madsen, Bradley Spencer-Dene, Richard Poulsom, et al.
Mechanisms of Development|October 1, 2003
Characterisation and developmental expression of mouse Plu-1, a homologue of a human nuclear protein (PLU-1) which is specifically up-regulated in breast cancerBente Madsen, Bradley Spencer-Dene, Richard Poulsom, et al.
Pageof 1